Growth Metrics

Marchex (MCHX) EBIT (2016 - 2025)

Marchex (MCHX) has disclosed EBIT for 16 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For Q4 2025, EBIT rose 19.04% year-over-year to $2.3 million; the TTM value through Dec 2025 reached -$1.1 million, down 13.14%, while the annual FY2025 figure was -$1.1 million, 12.93% down from the prior year.
  • EBIT was $2.3 million for Q4 2025 at Marchex, up from -$941000.0 in the prior quarter.
  • The five-year high for EBIT was $2.3 million in Q4 2025, with the low at -$5.2 million in Q1 2021.
  • Historically, EBIT has averaged -$1.6 million across 5 years, with a median of -$1.5 million in 2022.
  • The largest annual shift saw EBIT plummeted 194.12% in 2023 before it skyrocketed 269.58% in 2024.
  • Over 5 years, EBIT stood at -$1.8 million in 2021, then crashed by 96.98% to -$3.5 million in 2022, then soared by 68.17% to -$1.1 million in 2023, then skyrocketed by 269.58% to $1.9 million in 2024, then rose by 19.04% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $2.3 million in Q4 2025, -$941000.0 in Q3 2025, and -$536000.0 in Q2 2025.